Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 008371/0136 | |
| Pages: | 6 |
| | Recorded: | 02/24/1997 | | |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/05/2007
|
Application #:
|
08182183
|
Filing Dt:
|
05/23/1994
|
|
Title:
|
NUCLEIC ACIDS ENCODING GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF)
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/31/1998
|
Application #:
|
08446383
|
Filing Dt:
|
05/22/1995
|
|
Title:
|
METHODS OF USING GDNF AS A NEUROPROTECTIVE AGENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/25/2000
|
Application #:
|
08451374
|
Filing Dt:
|
05/26/1995
|
|
Title:
|
GLIAL DERIVED NEUROTROPHIC FACTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/26/2002
|
Application #:
|
08452229
|
Filing Dt:
|
05/26/1995
|
|
Title:
|
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/10/1999
|
Application #:
|
08452242
|
Filing Dt:
|
05/26/1995
|
|
Title:
|
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR ANTIBODY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/18/2000
|
Application #:
|
08453176
|
Filing Dt:
|
05/30/1995
|
|
Title:
|
IMPLANTABLE DEVICE CONTAINING GDNF SECRETING CELLS FOR TREATING NERVE DAMAGE AND METHODS OF USE
|
|
|
Assignee
|
|
|
|
|
| 1840 DEHAVILLAND DRIVE |
| THOUSAND OAKS, CALIFORNIA 91320 |
|
|
Correspondence name and address
|
| |
AMGEN
|
| |
DANIEL R. CURY
|
| |
U.S. PATENT OPERATIONS/DRC, DEPT. 431
|
| |
1840 DEHAVILLAND DRIVE
|
| |
THOUSAND OAKS, CALIFORNIA 91320-1789
|
Search Results as of:
05/05/2024 05:04 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
